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ABSTRACT
Alcohol-mediated liver injury is associated with changes in the level of the major cellular antioxidant
glutathione (GSH). It is interesting to investigate if the changes in intracellular GSH level through
exogenous agents affect the intracellular cysteine content and the protein adduct formation indicative
of oxidative insult in chronic alcohol treated liver cells. In VL-17A cells treated with 2mM N-acetyl cyst-
eine (NAC) or 0.1mM ursodeoxycholic acid (UDCA) plus 100mM ethanol, an increase in cysteine con-
centration which was accompanied by decreases in hydroxynonenal (HNE) and glutathionylated
protein adducts were observed. Pretreatment of 100mM ethanol treated VL-17A cells with 0.4mM
buthionine sulfoximine (BSO) or 1mM diethyl maleate (DEM) had opposite effects. Thus, altered GSH
level through exogenous agents may either potentiate or ameliorate chronic alcohol-mediated protein
adduct formation and change the cysteine level in chronic alcohol treated VL-17A cells. The gene
expression of non-treated and ethanol-treated hepatocytes in 2 microarray datasets was also compared
to locate differentially expressed genes involved in cysteine metabolism. The study demonstrates that
increased protein adducts formation and changes in cysteine concentration occur under chronic alco-
hol condition in liver cells which may increase alcohol-mediated oxidative injury.
ARTICLE HISTORY
Received 6 September 2016
Revised 14 November 2016
Accepted 30 November 2016
KEYWORDS
Alcohol; GSH; oxidative
injury; CYP2E1; intracellular
cysteine
Introduction
Glutathione (GSH) is ubiquitous in all animal cells, acts as a
scavenger for reactive oxygen species (ROS) and a detoxifica-
tion agent which conjugates with xenobiotics leading to their
subsequent elimination from the cell (Mari & Cederbaum,
2000; Meister, 1995). Oxidative stress and changes in redox
status characterize all forms of liver diseases (Yuan &
Kaplowitz, 2009). One of the major mechanisms for the hep-
atotoxicity of ethanol involves induction of cytochrome
P4502E1 (CYP2E1) and the subsequent formation of ROS and
lipid peroxidation derivatives (Mari & Cederbaum, 2000). The
relationship between GSH and alcohol-mediated liver injury
varies, in some instances GSH, including the mitochondrial
GSH is elevated (Bailey et al., 2001; Chandrasekaran et al.,
2010), whereas in other studies, decreased GSH level are
observed (Bansal et al., 2010; Waly et al., 2011).
One of the major determinants of the rate of GSH synthe-
sis is the availability of cysteine (Lu, 1999; Tateishi et al.,
1974). Cysteine differs from other amino acids since its sulf-
hydryl form, cysteine, is predominant inside the cell whereas
its disulfide form, cystine is predominant outside the cell
(Lu, 1999). GSH serves as a reservoir for cysteine because
extracellular cysteine is extremely unstable and rapidly auto-
oxidizes to cystine, generating ROS in the process (Lu, 1999;
Vina et al., 1983).
Cysteine is readily taken up by most if not all cells (Lu,
1999). Once inside the cell, the majority of cysteine is incor-
porated into GSH; and the rest is incorporated into protein
or degraded into sulfate and taurine (Lu, 1999). For most
cells, this mechanism provides a continuous source of cyst-
eine. Thus, the gamma-glutamyl cycle allows the efficient
utilization of GSH as cysteine storage (Lu, 1999).
N-Acetyl cysteine (NAC) contributes cysteine as a building
block for GSH synthesis thus increasing GSH content (Estrela
et al., 1983). Ursodeoxycholic acid (UDCA) increases the tran-
scription of gamma glutamyl cysteine synthetase thus
increasing the enzymatic efficiency (Mitsuyoshi et al., 1999).
GSH depletion by buthionine sulfoximine (BSO) inhibits
gamma-glutamylcysteine synthetase, the rate-limiting enzyme
for GSH synthesis (Mari & Cederbaum, 2000). Diethyl maleate
(DEM) depletes GSH through conjugation with GSH (Mitchell
et al., 1983).
One of the aims of the study was to investigate the
changes in intracellular cysteine concentration due to chronic
alcohol and GSH supplementation or depletion. The study
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also investigated the role of GSH as a protective mechanism
against chronic alcohol mediated oxidative adduct formation.
In order to study the above parameters, the present study
employed the recombinant VL-17A cells over-expressing alco-
hol dehydrogenase (ADH) and CYP2E1 and HepG2 cells
devoid of ADH and CYP2E1 expression pretreated with NAC
or UDCA or BSO or DEM and then exposed to chronic alco-
hol (100mM ethanol). Further the differential expression of
genes involved in cysteine metabolism in alcoholic liver was
also studied using microarray datasets (from Gene Expression
Omnibus – GEO) and BRB array tool.
Materials and methods
Chemicals
Minimal essential medium (MEM), phosphate buffered saline
(PBS), L-glutamine, and trypsin were obtained from Himedia,
Mumbai, India. Fetal bovine serum, the antibiotics zeocin,
geneticin, and gentamicin were obtained from Invitrogen
(Carlsbad, CA). The antibody for reduced glutathione was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Other chemicals used were obtained from Sigma-Aldrich (St.
Louis, MO). All chemicals were of the highest quality com-
mercially available.
Cell culture and treatment
HepG2 cells, which do not express ADH and CYP2E1 and VL-
17A cells, which are HepG2 cells constitutively expressing
ADH and CYP2E1 were used for the study (Donohue et al.,
2006). HepG2 cells were obtained from National Center for
Cell Sciences, Pune, India. VL-17A cells were kindly provided
by Dr. DL Clemens, University of Nebraska Medical Center
and Veterans Affairs Medical Center, Nebraska USA. HepG2
and VL-17A cells were cultured in MEM containing 10% fetal
bovine serum containing 2mM L-glutamine and 50 lg/ml
gentamicin in a humidified atmosphere in 5% CO2 at 37 C.
Further, VL-17A cells were cultured in the presence of zeocin
(selective for ADH) and geneticin (selective for CYP2E1) each
at 400 lg/ml. Cells were plated for 24 h before being treated
with the different chemicals at the indicated concentrations
for the different experiments.
Experiments were performed with 2mM NAC
(Chandrasekaran et al., 2010) or 0.1mM UDCA (Mitsuyoshi
et al., 1999) as GSH supplementing agents or 0.4mM BSO
(Mari & Cederbaum, 2000) or 1mM DEM (Hassan et al., 1992)
as GSH-depleting agents. Both HepG2 and VL-17A cells were
each divided into 10 experimental groups and the culture
duration with or without the different agents was 72 h except
otherwise indicated: (1) untreated cells in the first group
served as the control; (2) cells treated with 100mM ethanol
(chronic alcohol); (3) cells treated with 2mM NAC; (4) cells
treated with 0.1mM UDCA; (5) cells treated with 0.4mM BSO;
(6) cells treated with 1mM DEM for 2 h; (7) cells treated
with 2mM NAC plus 100mM ethanol; (8) cells treated with
0.1mM UDCA plus 100mM ethanol; (9) cells treated
with 0.4mM BSO plus 100mM ethanol; and (10) cells treated
with 1mM DEM (for 2 h only) plus 100mM ethanol.
Measurement of 4-hydroxynonenal adduct formation
Immunostaining for 4-hydroxynonenal (HNE) adduct forma-
tion was performed according to a method which was
described previously (Chandrasekaran et al., 2010) in
untreated liver cells, liver cells treated with 100mM ethanol
for 72 h, and liver cells treated with the different agents as
indicated above with or without 100mM ethanol for 72 h.
Detection of glutathionylated protein adduct formation
The formation of glutathionylated protein adducts was
detected through immunostaining by a slight modification of
the method described by Palanisamy et al. (2011) in
untreated HepG2 and VL-17A cells, HepG2 and VL-17A cells
treated with 100mM ethanol for 72 h and HepG2 and VL-17A
cells treated with the different agents as indicated above
with or without 100mM ethanol for 72 h. Briefly described,
the liver cells were washed with PBS and fixed with methanol
for 5min at 10 C and left air dried. After washing with PBS
(3), endogenous peroxidase was quenched by incubating
the cells with 3% H2O2 (in PBS) for 10min at room tempera-
ture. Further, after washing with PBS (2), the fixed cells
were treated with 5% non-fat milk for 1 h (blocking solution).
The blocking solution was removed, cells were washed with
PBS for 5min and incubated for 3 h with mouse anti-GSH pri-
mary antibody (reacts with glutathione-protein complexes) at
1:400 dilution. After washing with PBS for 5min (3), cells
were incubated with the secondary antibody conjugated
with HRP at 1:200 dilution for 30min. After washing with PBS
for 5min (2), cells were incubated in 0.05% of diaminoben-
zidine for 15min in dark, the staining developed was
observed under light microscope.
Intracellular cysteine concentration
The intracellular cysteine concentration was measured by
using a modified protocol of Gaitonde (1967) (Dominy et al.,
2007; Gaitonde, 1967) in untreated liver cells, liver cells
treated with 100mM ethanol for 72 h, and liver cells treated
with the different agents as indicated above with or without
100mM ethanol for 72 h. Briefly, the method consisted of
treating liver cells with 250 ll of 5% sulfosalicylic acid fol-
lowed by centrifugation at 15,000 g for 15min. The pH of the
supernatant was adjusted to 8.3 using 10 N NaOH, then
5mM dithiothreitol was added to it and the mixture was
kept at room temperature for 15min. Glacial acetic acid and
acidified ninhydrin reagent (250 ll each) were added to
250 ll of the above solution, the reaction mixture was boiled
at 100 C for 10min and the final volume was adjusted with
95% ethanol to 1ml. The absorbance was measured at
560 nm and the cysteine concentration was quantified using
a cysteine hydrochloride standard.
Data mining and meta-analysis
To study the expression of genes related to cysteine metab-
olism under ethanol (EtOH) treatment, 2 microarray datasets
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from (GEO) under the accession numbers GSE10285 and
GSE52644 (Tatsukawa et al., 2009; Yao et al., 2014) were
retrieved. GSE10285 dataset contained the gene expression
profiles of TG2þ/þ (transglutaminase 2) and TG2/ mice
primary hepatocytes treated with or without 100mM ethanol.
GSE52644 dataset contained the gene expression data of
C3H/HeN female mice (wild type or constitutive androstane
receptor deficient) fed with Lieber's isocaloric diet containing
water, or containing ethanol, or containing ethanol and
ellagic acid or containing ethanol and trans-resveratrol for 1
week. The gene expression of control (non-treated) and etha-
nol-treated hepatocytes in both the datasets (GSE10285 &
GSE52644) were compared using BRB-array tools.
Statistical analysis
The data represent the results of three experiments and is
presented as mean± SE. One-way ANOVA followed by
Bonferroni post-hoc test was performed to analyze results
between the different groups. p< .05 was considered to be
statistically significant.
Results
Changes in HNE adduct formation in 100mM alcohol-
treated VL-17A cells with GSH supplementation or
depletion
HNE adduct formation was not evident in untreated HepG2
cells (Figure 1). HepG2 cells treated with 100mM
ethanol were characterized by the complete absence of HNE
adduct formation. In contrast, 100mM ethanol treated VL-
17A cells exhibited extensive HNE adduct formation.
HepG2 cells treated with 2mM NAC or 0.1mM UDCA plus
100mM ethanol exhibited a complete lack of HNE adduct
formation. However, 2mM NAC or 0.1mM UDCA plus
100mM ethanol-pretreated VL-17A cells were characterized
by a minimal presence of HNE adduct formation. While
0.4mM BSO or 1mM DEM plus 100mM ethanol-treated
HepG2 cells did not exhibit HNE formation, 0.4mM BSO or
1mM DEM plus 100mM ethanol-treated VL-17A cells exhib-
ited increased HNE formation.
Changes in glutathionylated protein adduct formation
in 100mM alcohol treated VL-17A cells with GSH
supplementation or depletion
Untreated HepG2 and VL-17A cells and HepG2 cells treated
with 100mM ethanol were characterized by a complete lack
of glutathionylated protein adduct formation (Figure 2).
VL-17A cells treated with 100mM ethanol were characterized
by a large number of cells showing dark brown staining due
to glutathionylated protein adduct formation.
In HepG2 cells treated with 100mM ethanol or 2mM NAC
or 0.1mM UDCA or 0.4mM BSO or 1mM DEM plus 100mM
ethanol, glutathionylated protein adduct formation was not
evident. Pretreatment of 100mM ethanol-treated VL-17A cells
with 2mM NAC or 0.1mM UDCA decreased the glutathiony-
lated protein adduct formation when compared with 100mM
ethanol treated VL-17A cells, as observed through decrease
in the intensity of the staining accompanied by increased
cluster formation of cells. VL-17A cells treated with 0.4mM
BSO or 1mM DEM plus 100mM ethanol exhibited an
Figure 1. Effect of GSH supplementation or depletion on HNE-protein adduct formation. HepG2 and VL-17A cells were treated with 100mM ethanol or 2mM NAC
or 0.1mM UDCA or 0.4mM BSO or 1mM DEM plus 100mM ethanol for 72 hours. HNE-protein adduct formation was detected by staining with anti-4-HNE
(Santa Cruz Biotechnologies, USA) antibody. One representative experiment of three is shown. Bar: 20 lm.
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increase in glutathionylated protein adduct formation when
compared with 100mM ethanol-treated VL-17A cells along
with a fewer number of cells.
Changes in cysteine concentration in 100mM alcohol-
treated VL-17A cells with GSH supplementation or
depletion
Untreated HepG2 cells exhibited a 2.1-fold significantly
higher intracellular cysteine concentration than the corre-
sponding group of VL-17A cells (Figure 3). While HepG2 cells
treated with 100mM ethanol did not exhibit altered intracel-
lular cysteine concentration, VL-17A cells treated with
100mM ethanol exhibited a 1.1-fold significantly decreased
intracellular cysteine concentration when compared with
untreated VL-17A cells.
Treatment of HepG2 cells with 2mM NAC or 0.1mM
UDCA plus 100mM ethanol did not significantly change
intracellular cysteine concentration when compared with
100mM ethanol-treated HepG2 cells. VL-17A cells treated
with 2mM NAC or 0.1mM UDCA plus 100mM ethanol exhib-
ited a 1.3-fold significantly higher intracellular cysteine con-
centration when compared with 100mM ethanol-treated VL-
17A cells.
Treatment of HepG2 cells with 0.4mM BSO or 1mM DEM
plus 100mM ethanol did not cause significant changes in
intracellular cysteine concentration when compared with
100mM ethanol treated HepG2 cells. Treatment of VL-17A
cells with 0.4mM BSO or 1mM DEM plus 100mM ethanol
caused 1.2–1.5-fold significant decreases in intracellular
cysteine concentration when compared with 100mM ethanol
treated VL-17A cells
Identification of differentially expressed genes in
100mM ethanol-treated murine hepatocytes and their
putative roles in cysteine metabolism
The microarray datasets GSE10285 and GSE52644 were ana-
lyzed using BRB-array tools. In the GSE10285 dataset,
17,387 genes showed minimum spot intensity of 10 and a
fold change of 1.5 in at least 20% of the arrays. Out of
which, 2800 genes were significantly differentially expressed
with the p value .05 in 100mM ethanol treated hepato-
cytes. Ninety genes were significant at the nominal level
0.001 of the univariate test in which 11 genes were up-
regulated and 79 genes were down-regulated in 100mM
ethanol-treated hepatocytes which are given as heatmaps
(Figure 4 (A)).
Out of the differentially expressed genes (DEGs), Got2
gene has been found to be associated with cysteine metab-
olism (Cresenzi et al., 2003). In a transgenic mouse model of
Cystathionine b-synthase (cysteine synthase)-deficient homo-
cystinuria, the expression of mitochondrial glutamic-oxaloace-
tic transaminase or aspartate aminotransferase (GOT2) was
found to be repressed (Jiang et al., 2014).
GSE52644 dataset revealed 54 DEGs with the p value of
0.05. Comparison of the two datasets showed six genes in
common which include Stom, Sh3glb1, Hsd17b7, M6pr,
Khdrbs1, and Ccne1 whose significance in cysteine metabol-
ism is not currently known (Figure 4(B)).
Figure 2. Effect of GSH supplementation or depletion on glutathionylated protein adduct formation in HepG2 and VL-17A cells. HepG2 and VL-17A cells were
treated with 100mM ethanol or 2mM NAC or 0.1mM UDCA or 0.4mM BSO or 1mM DEM plus 100mM ethanol for 72 hours. Glutathionylation of protein was
detected by staining liver cells with anti-GSH antibody. Bar: 20 lm.
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Discussion
In the present study, the effects of the modulation of GSH
through exogenous antioxidants and GSH depleting agents
on chronic alcohol mediated protein adduct formation in
liver were investigated, suggesting alcohol-mediated oxida-
tive damage. Cysteine serves as a crucial rate-limiting sub-
strate for GSH synthesis (Lu, 1999; Tateishi et al., 1974).
Further, in order to understand the mechanisms involved in
changes in GSH homeostasis due to co-exposure of liver cells
to chronic alcohol and exogenous GSH supplementation or
depletion, the changes in intracellular cysteine concentration
were studied.
All groups of HepG2 cells were characterized by a com-
plete lack of HNE adduct formation. VL-17A cells treated with
100mM ethanol exhibited HNE adduct formation which were
decreased with pretreatment with 2mM NAC or 0.1mM
UDCA. VL-17A cells treated with 0.4mM BSO or 1mM DEM
plus 100mM ethanol were characterized by the presence of
extensive HNE adduct formation. As illustrated with the HNE
adduct formation, the results decisively show that while
exogenous GSH supplementation effectively decreases oxida-
tive stress, a reverse phenomenon is observed with exogen-
ous GSH depletion in 100mM ethanol-treated VL-17A cells.
Deprivation of GSH in cells may lead to oxidative stress in
cells since their redox equilibrium is altered and their ability
to scavenge or detoxify ROS is impaired (Ghibelli et al.,
1998). Depletion of GSH itself could lead to oxidative stress,
independently of ROS generation (Ghibelli et al., 1998).
Therefore, the exogenous addition of GSH ameliorates oxida-
tive insult and the depletion of GSH exacerbates it further in
100mM ethanol treated VL-17A cells, thus modulating alco-
hol-mediated oxidant injury.
Glutathionylated protein adducts which are formed in
response to the cellular oxidative stress (Townsend, 2007)
were not evident in untreated liver cells or liver cells treated
with the GSH supplementing or depleting agents.
Glutathionylated protein adduct formation was not evident
in 100mM ethanol-treated HepG2 cells but the correspond-
ing group of VL-17A cells was characterized by the presence
of extensive glutathionylated protein adduct formation. While
pretreatment of 100mM ethanol treated VL-17A cells with
2mM NAC or 0.1mM UDCA decreased the glutathionylated
protein adduct formation, 0.4mM BSO or 1mM DEM
increased the glutathionylated protein adduct formation.
Protein S-glutathionylation occurs in vivo due to the thiol/
disulfide exchange mechanism (Gilbert, 1995), which occurs
when an oxidative attack leads to altered GSH/oxidized gluta-
thione (GSSG) ratio and induces GSSG to bind to protein thi-
ols (Pastore et al., 2003). Several important metabolic
enzymes, transcription factors, and ubiquitin-activating
enzymes are affected through protein glutathionylation
(Pastore et al., 2003). Increased protein S-glutathionylation
rate is associated with endoplasmic reticulum (ER) stress in
some diseases and this overlap likely reflects signals emanat-
ing from the ER as it processes proteins that respond (e.g.,
by undergoing S-glutathionylation) to cellular redox condi-
tions (Townsend, 2007).
HepG2 cells exhibited higher intracellular cysteine concen-
tration than VL-17A cells, consistent with our observation of
lower GSH level in HepG2 cells than VL-17A cells (data not
shown). This implicates the utilization of cysteine in GSH syn-
thesis, i.e. increased GSH level in VL-17A cells correlates with
decreased cysteine level in VL-17A cells.
Since the cysteine concentration in 100mM ethanol-
treated HepG2 cells was not changed when compared with
the untreated HepG2 cells, treatment of 100mM ethanol-
treated HepG2 cells with either 2mM NAC or 0.1mM UDCA
or 0.4mM BSO or 1mM DEM did not change cysteine level
further. However, 100mM ethanol decreased cysteine con-
centration in VL-17A cells, a possible consequence of its
Figure 3. Effect of GSH supplementation or depletion on intracellular cysteine concentration in HepG2 and VL-17A cells. HepG2 and VL-17A cells were treated with
100mM ethanol or 2mM NAC or 0.1mM UDCA or 0.4mM BSO or 1mM DEM plus 100mM ethanol for 72 hours. Intracellular cysteine concentration was assayed by
ninhydrin method. Results are expressed as mean ± S.E of three experiments. p< .05 compared with untreated HepG2 or VL-17A cells, u p< .05 compared with
100mM ethanol treated HepG2 cells, 6¼ p< .05 compared with untreated HepG2 cells, #p< .05 compared with 100mM ethanol treated HepG2 or VL-17A cells.
132 S. M. KUMAR ET AL.
utilization in GSH synthesis and, therefore, increased GSH
level (data not shown).
While 2mM NAC or 0.1mM UDCA increased cysteine con-
centration in 100mM ethanol treated VL-17A cells, 0.4mM
BSO or 1mM DEM decreased the cysteine concentration. It is
a well-established fact that both NAC and UDCA increase
GSH synthesis through different mechanisms: NAC being a
cysteine precursor (Estrela et al., 1983) and UDCA affecting
the gamma glutamyl cysteine synthetase (Mitsuyoshi et al.,
1999); therefore, the increase in cysteine with 2mM NAC or
0.1mM UDCA is not surprising. Cysteine concentration was
decreased with 0.4mM BSO or 1mM DEM plus 100mM etha-
nol, implicating the lesser availability of cysteine for its util-
ization in GSH synthesis and in a larger context, impaired
synthesis of other cellular proteins (Stipanuk et al., 2006).
An increase in intracellular cysteine level leads to
increased GSH synthesis which is a consequence of increased
saturation of glutamate–cysteine ligase with cysteine, and
this contributes to the removal of excess cysteine (Stipanuk
et al., 2006). A decrease in cysteine level also leads to
increased glutamate–cysteine ligase activity and the
increased capacity for GSH synthesis facilitates conservation
Figure 4. Identification of differentially expressed genes in 100mM ethanol treated murine hepatocytes with putative roles in cysteine metabolism. (A) Heatmap of
up-regulated and down-regulated genes in 100mM ethanol treated group compared to control corresponding to the dataset GSE10285. (B) Venn diagram showing
the number of differentially expressed genes in 100mM ethanol treated group common in between the datasets GSE10285 and GSE52644.
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of cysteine in the form of GSH (Stipanuk et al., 2006). A very
narrow range of cysteine levels ensures that the liver fulfills
the two opposing homeostatic requirements (Stipanuk et al.,
2006). On one hand, sufficiently high cysteine level is
required to meet the needs of protein synthesis and the
generation of other essential molecules that include GSH,
coenzyme A, taurine, and inorganic sulfur (Stipanuk et al.,
2006). On the other hand, cysteine concentrations must
also be kept below the threshold of cytotoxicity (Stipanuk
et al., 2006).
Since changes in cysteine concentration occurred due to
100mM ethanol-treated VL-17A cells with or without GSH
modulation, and cysteine being crucial for GSH synthesis, it
was interesting to investigate if the genes expressed in alco-
holic liver are involved in cysteine metabolism. Comparison
of micro array data sets obtained from 100mM ethanol
treated murine hepatocytes revealed several differentially
expressed genes in which the role of Got2 in cysteine metab-
olism is known till now. Aspartate aminotransferase catalyzes
the transamination reaction of cysteine desulfuration path-
way which redirects cysteine sulfinate towards pyruvate syn-
thesis. In hepatocytes, the intracellular cysteine level is
regulated either by incorporation to GSH or oxidation of cyst-
eine to cysteine sulfinate (Cresenzi et al., 2003).The fate of
oxidized cysteine, cysteine sulfinate, is to enter decarboxyl-
ation catalyzed by cysteine sulfinate decarboxylase for taur-
ine production or to get transaminated by aspartate
aminotransferase to form pyruvate (Stipanuk & Rotter, 1984;
Stipanuk & Ueki, 2011). Based on our microarray data ana-
lysis, it could be predicted that the reduced expression of
Got2 gene-encoded aspartate aminotransferase may enhance
the ethanol-mediated taurine production. The reduced
expression of Got2 gene in alcoholic liver favors the taurine
synthesis in the hepatocytes as observed in a study involving
rats administered with acute alcohol treatment (Jung et al.,
2003). The authors concluded that ethanol depresses the
cysteine availability for GSH synthesis not only by inhibiting
the transsulfuration reactions but also by enhancing its irre-
versible catabolism to taurine (Jung et al., 2003). Further,
taurine treatment has been shown to reverse hepatic stea-
tosis induced by chronic alcoholic consumption (Kerai et al.,
1999). Collectively the current study represents the import-
ance of cysteine regulation in the development of alcoholic
liver disease.
The results of the present study show that exogenous
GSH supplementation with 2mM NAC or 0.1mM UDCA in
VL-17A cells pretreated with 100mM ethanol leads to
increases in cysteine concentration. Further the NAC or UDCA
plus ethanol-treated VL-17A cells showed decreased HNE and
glutathionylated protein adducts. In contrast, GSH depletion
through 0.4mM BSO or 1mM DEM in 100mM ethanol-
treated VL-17A cells decreased the cysteine level thus
restricting its availability for GSH synthesis. Oxidative stress
was higher as demonstrated through the HNE and glutahio-
nylated protein adduct formation under chronic alcohol plus
GSH-depleted VL-17A cells. Comparison of gene expression in
2 microarray data sets of non-treated and ethanol-treated
hepatocytes revealed several differentially expressed genes,
among which Got2 which encodes aspartate
aminotransferase has been found to be involved in cysteine
metabolism till date. In conclusion, modulating GSH level
with exogenous agents such as NAC, UDCA, BSO, or DEM in
liver cells leads to changes in the oxidative environment
which includes differential regulation of the various cellular
processes affected by alcohol such as intracellular cysteine
level and protein adduct formation.
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